Lesinurad/Allopurinol 200/300 Fixed-Dose Combination (FDC) Tablets Bioequivalence.

Trial Identifier:	RDEA594-504
Sponsor:	Ardea Biosciences, Inc.
NCTID::	NCT03272425
Start Date:	August 2017
Primary Completion Date:	October 2017
Study Completion Date:	October 2017
Condition:	Immune, Inflammatory & Infections - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English translation
	Portuguese translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Brazil, Sao Paulo	Campinas, Sao Paulo, Brazil

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.